The John Hopkins Center for Psychedelic and Consciousness Research Publishes Inaugural Edition Of Newsletter
Cannabis Law Report
NOVEMBER 24, 2019
Future studies will explore psilocybin’s effectiveness as a new therapy for opioid addiction, Alzheimer’s disease, post-traumatic stress disorder (PTSD), post-treatment Lyme disease syndrome (formerly known as chronic Lyme disease), anorexia nervosa, and alcohol use in people with major depression. Participate in Our Studies.
Let's personalize your content